This is a list of all the questions and their associated study carrel identifiers. One can learn a lot of the "aboutness" of a text simply by reading the questions.
| identifier | question |
|---|---|
| cord-029774-j3pyadqi | primary nephrotic syndrome Relapse of minimal change disease following infection with the 2009 pandemic influenza( H1N1) virus Nephrotic syndrome following H1N1 influenza in a 3-year-old boy KDIGO clinical practice guideline for glomerulonephritis Efficacy of vaccination against viral hepatitis type B in children with the nephrotic syndrome Varicella vaccination in children with nephrotic syndrome: a report of the Southwest Pediatric Nephrology Study Group Varicella vaccination in children with steroid- sensitive nephrotic syndrome Risk of relapse after meningococcal C conjugate vaccine in nephrotic syndrome Hepatitis B virus vaccination in children with steroid sensitive nephrotic syndrome: immunogenicity and safety? |
| cord-009947-0zz4x8li | If vaccination has been so successful, then why is it necessary to continually re- evaluate vaccination practice? |
| cord-018497-oy7hsrpt | By using economic evaluation we are essentially trying to answer the following questions[ 5]: 1) Is the vaccination program under study worth doing compared to alternative ways of using the same resources? |
| cord-018497-oy7hsrpt | Discounting costs and effects: a reconsideration Discounting for health effects in cost- benefit and cost- effectiveness analysis Does NICE have a cost- effectiveness threshold and what other factors influence its decisions? |
| cord-018497-oy7hsrpt | In other words: should the( health care) resources be spent on such a vaccination program, and not on something else? |
| cord-018497-oy7hsrpt | More specifically, if we are deciding to vaccinate against a particular disease, whom should we vaccinate, at which age, with which vaccine and how should the vaccine be delivered and administered in order to deploy our scarce resources in the most efficient way? |
| cord-018497-oy7hsrpt | The question then is, how to determine K? |
| cord-258366-fu9b446y | Influenza vaccination among medical residents in a teaching hospital Influenza vaccination rates and motivators among healthcare worker groups Influenza immunisation: attitudes and beliefs of UK healthcare workers Attitudes of health care workers to influenza vaccination: why are they not vaccinated? |
| cord-003828-bhfghcby | A streptococcus and mammalian muscle Spreading of T- cell autoimmunity to cryptic determinants of an autoantigen Antiviral immune responses: triggers of or triggered by autoimmunity? |
| cord-003828-bhfghcby | Can vaccines cause MS and( ii) can vaccines provoke or trigger relapses in patients with MS? |
| cord-003828-bhfghcby | Targeting prohibitins at the cell surface prevents Th17-mediated autoimmunity Immunization in patients with multiple sclerosis Chlamydia pneumoniae infection of the central nervous system in multiple sclerosis Epstein- Barr virus and multiple sclerosis Coronaviruses in brain tissue from patients with multiple sclerosis Active human herpesvirus 6 infection in patients with multiple sclerosis Cerebrospinal fluid molecular demonstration of Chlamydia pneumoniae DNA is associated to clinical and brain magnetic resonance imaging activity in a subset of patients with relapsing- remitting multiple sclerosis Multiple sclerosis, sporadic creutzfeldt- jakob disease and bovine spongiform encephalopathy: are they autoimmune diseases evoked by acinetobacter microbes showing molecular mimicry to brain antigens? |
| cord-003828-bhfghcby | The neuro- paralytic accidents of antirabies treatment Autoimmune encephalitis in humans: how closely does it reflect multiple sclerosis? |
| cord-003828-bhfghcby | The risk of relapses in multiple sclerosis during systemic infections Relapsing encephalomyelitis following the use of influenza vaccine Ocular abnormalities after influenza immunization Acute transverse myelitis after influenza vaccination: magnetic resonance imaging findings Optic neuritis after influenza vaccination Diffuse myelitis associated with rubella vaccination Diffuse myelitis associated with rubella vaccination Transverse myelitis after measles, mumps, and rubella vaccine Optic neuritis complicating measles, mumps, and rubella vaccination Optic neuritis following measles/ rubella vaccination in two 13-year- old children Relapsing acute encephalopathy: a complication of diphtheria- tetanus- poliomyelitis immunization in a young boy Multiple sclerosis and vaccination Central- nervous- system demyelination after immunisation with recombinant hepatitis B vaccine Encephalitis after hepatitis B vaccination: recurrent disseminated encephalitis or MS? |
| cord-003828-bhfghcby | authors: Zrzavy, Tobias; Kollaritsch, Herwig; Rommer, Paulus S.; Boxberger, Nina; Loebermann, Micha; Wimmer, Isabella; Winkelmann, Alexander; Zettl, Uwe K. title: Vaccination in Multiple Sclerosis: Friend or Foe? |
| cord-004073-k6ad4qgu | A delay differential model for pandemic influenza with antiviral treatment A population- dynamic model for evaluating the potential spread of drug- resistant influenza virus infections during community- based use of antivirals Prophylaxis or treatment? |
| cord-004073-k6ad4qgu | Can influenza epidemics be prevented by voluntary vaccination? |
| cord-004073-k6ad4qgu | Coupled disease- behavior dynamics on complex networks: a review Effects of stubborn decision- makers on vaccination and disease propagation in social network Effect of noise- perturbing intermediate defense measures in voluntary vaccination games Realistic decision- making processes in a vaccination game Effect of intermediate defense measures in voluntary vaccination games Which is more effective for suppressing an infectious disease: imperfect vaccination or defense against contagion? |
| cord-004203-mkr7n1i0 | 8 Should health care workers undergo voluntary annual influenza vaccination? |
| cord-004203-mkr7n1i0 | Are there conditions under which mandatory vaccination of health care workers is fair? |
| cord-004203-mkr7n1i0 | As Gostin has asked:"how do we know when the public good to be achieved is worth the infringement of individual rights? |
| cord-004203-mkr7n1i0 | Do the conditions differ for physicians in private offices versus hospital workers? |
| cord-004203-mkr7n1i0 | How about volunteers? |
| cord-004203-mkr7n1i0 | In favour of mandatory influenza vaccine for all health care workers Virulent epidemics and scope of healthcare workers'duty of care Two concepts of liberty Point: Mandatory influenza vaccination for all health care workers? |
| cord-004203-mkr7n1i0 | Should health care workers be required to take antiviral drugs in addition to/ in lieu of vaccination? |
| cord-004203-mkr7n1i0 | Should mandatory influenza vaccination for health care workers be seen as protecting the public( public health context) or health care workers themselves( occupational health context)? |
| cord-004203-mkr7n1i0 | To what extent are health care workers justified in valuing personal interests over those of their patients-and potential patients? |
| cord-004203-mkr7n1i0 | To what extent are health care workers responsible for potentially vulnerable populations, or the community at large? |
| cord-004203-mkr7n1i0 | Was the Ontario government just in its efforts to impose compulsory influenza vaccination for paramedics in 2000? |
| cord-004203-mkr7n1i0 | What ’s Private?: |
| cord-004203-mkr7n1i0 | What ’s Public? |
| cord-276363-m8di6dpt | fü r die Grippeschutzimpfung? |
| cord-285306-leu2hygk | A rapid review of current evidence Does BCG vaccination protect against acute respiratory infections and COVID-19? |
| cord-285306-leu2hygk | Does BCG vaccination protect against acute respiratory infections and COVID 19? |
| cord-010266-elhgew3x | And indeed, is it ethical that a person in the vaccine- producing country should enjoy the benefits which have been won at the expense of the risk- taking of a person in less privileged circumstances? |
| cord-010266-elhgew3x | Are the conditions leading to infection and the challenge organisms relevant? |
| cord-010266-elhgew3x | Are the people in whom the vaccine is tested likely to respond in an immunologically equivalent manner when the history of the exposure of their immune systems to disease is dissimilar in many ways to a person of the Developed World? |
| cord-010266-elhgew3x | But how safe is safe? |
| cord-010266-elhgew3x | But is this the appropriate ethic? |
| cord-010266-elhgew3x | Does this mean that the rich should pay a high price for a vaccine and thus subsidize the provision of cheap vaccines to the poor? |
| cord-010266-elhgew3x | For example, is it possible to obtain the informed consent of a person who is illiterate and who does not understand the implications of something like a vaccine with which( s)he is totally unfamiliar? |
| cord-010266-elhgew3x | In the event that there is damage to an individual as a result of exposure to vaccine in a trial, what are the levels of compensation and who pays? |
| cord-010266-elhgew3x | Is it appropriate to use a technical fix when an almost cost- free change of behaviour will achieve the same effect? |
| cord-010266-elhgew3x | May not the society, in accepting the benefit of widespread vaccination, compensate those who suffer damage at a level communsurate with the damage? |
| cord-010266-elhgew3x | One might ask, to what extent is a prophylactic trial in the Developing World relevant to the circumstances prevalent in the Developed World? |
| cord-010266-elhgew3x | Or is it the job of the elected representatives of the people to act as purchaser on behalf of the poor and provide the vaccine manufacturer compensation through the tax system or other fiscal dispensation? |
| cord-010266-elhgew3x | The question which this poses is, do those who have opted against vaccination have the right to benefit from the expense and the risks of vaccine- induced damage accepted by those who have been vaccinated? |
| cord-010266-elhgew3x | Were the genes of that cell to be used to make a pharmaceutical to particularly benefit people in the Developed World, what sort of compensation should acrue to the source of the cell line from which the gene was obtained? |
| cord-010266-elhgew3x | and what are the limits by which we define consistency? |
| cord-010266-elhgew3x | and what is efficacious? |
| cord-011245-nkr0998x | : what is the evidence? |
| cord-011245-nkr0998x | Addressing parents'concerns: do multiple vaccines overwhelm or weaken the infant's immune system? |
| cord-011245-nkr0998x | The ITP syndrome: pathogenic and clinical diversity Virus- associated immune thrombocytopenic purpura in childhood Association between drug and vaccine use and acute immune thrombocytopenia in childhood Vaccine administration and the development of immune thrombocytopenic purpura in children Risk of immune thrombocytopenic purpura after measles- mumps- rubella immunization in children MMR vaccine and idiopathic thrombocytopaenic purpura Immune thrombocytopaenic purpura: an autoimmune cross- link between infections and vaccines Thrombocytopenia reported in association with hepatitis B and A vaccines Consequence or coincidence? |
| cord-011245-nkr0998x | Who are they and where do they live? |
| cord-264522-u61m4x9l | : Do You Know your Incident Command System? |
| cord-264522-u61m4x9l | W ho watches the watchers? |
| cord-264522-u61m4x9l | Will carrots or sticks raise influenza immunization rates of health care personnel? |
| cord-258626-p469ysi8 | ( although a specific disease may not commonly be seen, the organism is ubiquitous in the environment and therefore poses risk to the individual or population);( 3) the risk of the individual for exposure to the disease( indoor- only animal vs free- roaming individual, regional variations of occurrence);( 4) the efficacy of the vaccine( does the vaccine prevent infection or simply ameliorate some signs or length of disease?);( 5) the risks associated with administering the vaccine( are the risks associated with that vaccine greater than the risk of the disease?);( 6) the potential for zoonotic disease;( 7) the route of infection or transmissibility. |
| cord-258626-p469ysi8 | ( although a specific disease may not commonly be seen, the organism is ubiquitous in the environment and therefore poses risk to the individual or population);( 3) the risk of the individual for exposure to the disease( indoor- only animal vs free- roaming individual, regional variations of occurrence);( 4) the efficacy of the vaccine( does the vaccine prevent infection or simply ameliorate some signs or length of disease?);( 5) the risks associated with administering the vaccine( are the risks associated with that vaccine greater than the risk of the disease?);( 6) the potential for zoonotic disease;( 7) the route of infection or transmissibility. |
| cord-258626-p469ysi8 | Criteria for assigning vaccines into these categories, and a third category,"generally not recommended,"are based on:( 1) morbidity and mortality associated with the specific disease( does the organism cause serious illness or does it cause a mild, transient disease that may pose only minimal risk to the individual or population?); |
| cord-258626-p469ysi8 | If an owner brings a Labrador retriever puppy to the veterinarian for"whatever vaccines he needs,"it is up to the practitioner to ask"will he be a hunting dog, will he be used in field trials, will he be exposed to wildlife and waterways?" |
| cord-258626-p469ysi8 | Who better to disseminate knowledge about veterinary medicine to the general public than veterinarians? |
| cord-002137-j5sfiyz8 | : how can we improve the uptake of influenza vaccine? |
| cord-275538-c44gmu22 | Efficacy of the vaccine( does the vaccine prevent infection or simply ameliorate some signs or length of the disease?) |
| cord-275538-c44gmu22 | If an owner brings a Labrador Retriever puppy to the veterinarian for''whatever vaccines it needs,''it is up to the practitioner to ask:''Will it be a hunting dog, will it be used in field trials, or will it be exposed to wildlife and waterways?'' |
| cord-275538-c44gmu22 | Morbidity and mortality associated with the specific disease( does the organism cause serious illness, or does it cause a mild transient disease that may pose only minimal risk to the individual or population?) |
| cord-275538-c44gmu22 | Risks associated with administering the vaccine( are the risks associated with that vaccine greater than the risk of the disease?) |
| cord-287067-rrsgl377 | : how does the reality match the predictions? |
| cord-287067-rrsgl377 | Economic evaluations of childhood pneumococcal conjugate vaccination- a review The Global Burden of Disease Assessments- WHO is responsible? |
| cord-287067-rrsgl377 | However, a more simple approach, based on static models, could give insights on the basic question: should we vaccinate girls before their sexual debut? |
| cord-287067-rrsgl377 | Infl uenza vaccine eff ectiveness in healthy 6-to 21-month- old children during the 2003- 2004 season Interdisciplinary epidemiologic and economic research needed to support a universal childhood infl uenza vaccination policy School- based infl uenza vaccination program reduces infl uenza- related outcomes among household members Optimal allocation of pandemic infl uenza vaccine depends on age, risk and timing Convincing or confusing? |
| cord-287067-rrsgl377 | Is G8 putting profi ts before the world's poorest children? |
| cord-287067-rrsgl377 | The seroepidemiology of human papillomavirus infection in Australia Herd immunity: history, theory, practice Impact of model, methodological, and parameter uncertainty in the economic analysis of vaccination programs Evaluating the cost- eff ectiveness of vaccination programmes: a dynamic perspective Eff ectiveness of sevenvalent pneumococcal conjugate vaccine against invasive pneumococcal disease: a matched case- control study Cost- eff ectiveness of a routine varicella vaccination program for US children Theoretical epidemiologic and morbidity eff ects of routine varicella immunization of preschool children in the United States Impact of anti- vaccine movements on pertussis control: the untold story Eradication versus control for poliomyelitis: an economic analysis Compulsory vaccination and conscientious or philosophical exemptions: past, present, and future Improving uptake of MMR vaccine Cost- eff ectiveness analysis of changing from live oral poliovirus vaccine to inactivated poliovirus vaccine in Australia Poliomyelitis outbreak in an unvaccinated community in the Netherlands, 1992- 93 Cost- eff ectiveness of incorporating inactivated poliovirus vaccine into the routine childhood immunization schedule World wide experience with inactivated poliovirus vaccine Partially wrong? |
| cord-287067-rrsgl377 | Tiered pricing of vaccines: a win- win- win situation, not a subsidy Who benefi ts from new medical technologies? |
| cord-287067-rrsgl377 | do vaccines warrant a different approach? |
| cord-287067-rrsgl377 | thus potentially reshuffl ing the comparison between all health- care programmes( including the other vaccines discussed here)? |
| cord-000336-57es391o | An examination of theory and applications Multicollinearity and measurement error in structural equation models: implications for theory testing The 2009- 2010 influenza pandemic: effects on pandemic and seasonal vaccine uptake and lessons learned for seasonal vaccination campaigns Addressing parents'concerns: do vaccines contain harmful preservatives, adjuvants, additives, or residuals? |
| cord-000336-57es391o | And do the original TPB components and the additional components( extended social norms, anticipated regret and seasonal influenza vaccination history) contribute to peoples'decisions on vaccination uptake? |
| cord-000336-57es391o | Does vaccination planning mediate the relation between intention and future vaccination uptake? |
| cord-000336-57es391o | In this study, we aimed to answer the following research questions: How well does intention predict future uptake of pH1N1 vaccine? |
| cord-000336-57es391o | The impact of communications about swine flu( influenza A H1N1v) on public responses to the outbreak: results from 36 national telephone surveys in the UK Influenza vaccine coverage rates and perceptions on vaccination in South Korea Influenza vaccination coverage rates in five European countries- a population- based cross- sectional analysis of two consecutive influenza seasons What factors affect influenza vaccine uptake among community- dwelling older Chinese people in Hong Kong general outpatient clinics? |
| cord-000336-57es391o | The theory of planned behavior: a review of its applications to health- related behaviors Efficacy of the Theory of Planned Behaviour: a meta- analytic review Intention- behavior relations: a conceptual and empirical review Does changing behavioral intentions engender behavior change? |
| cord-000336-57es391o | What Drives Pregnant Women's Decisions to Accept the H1N1 Vaccine? |
| cord-000336-57es391o | What is coefficient alpha? |
| cord-000336-57es391o | Which factors are important in adults'uptake of a( pre)pandemic influenza vaccine? |
| cord-000336-57es391o | Why were Turks unwilling to accept the A/ H1N1 influenza- pandemic vaccination? |
| cord-000336-57es391o | lessons from current outbreaks Number of notifications for notifiable infectious diseases Human Swine Influenza Vaccination Programme Human Swine Influenza Vaccination Acceptability of A/ H1N1 vaccination during pandemic phase of influenza A/ H1N1 in Hong Kong: population based cross sectional survey Factors in association with acceptability of A/ H1N1 vaccination during the influenza A/ H1N1 pandemic phase in the Hong Kong general population Publicity Plan for Human Swine Influenza Vaccination Programme Statistics on human swine influenza vaccinations Press Releases Determinants of intention to get vaccinated against novel( pandemic) influenza A H1N1 among health- care workers in a nationwide survey Does receipt of seasonal influenza vaccine predict intention to receive novel H1N1 vaccine: evidence from a nationally representative survey of U.S. adults Factors in vaccination intention against the pandemic influenza A/ H1N1 Influenza vaccination and intention to receive the pandemic H1N1 influenza vaccine among healthcare workers of British Columbia, Canada: a cross- sectional study Intent to receive pandemic influenza A( H1N1) vaccine, compliance with social distancing and sources of information in NC Low acceptability of A/ H1N1 pandemic vaccination in French adult population: did public health policy fuel public dissonance? |
| cord-000336-57es391o | worry, regret, and influenza vaccination Risk perceptions: assessment and relationship to influenza vaccination Do people who intend to get a flu shot actually get one? |
| cord-294789-07hto8qn | People will judge a COVID-19 vaccination campaign's integrity not simply on biomedical merits, but on matters of fairness and equity- that is, have people received their just portion of health services, and has disease prevention, ultimately, been fairly distributed? |
| cord-294789-07hto8qn | Will Ebola change the game? |
| cord-302200-9gekjgr0 | What drives pregnant women's decisions to accept the H1N1 vaccine? |
| cord-302200-9gekjgr0 | What next for the coronavirus response? |
| cord-269402-xzgfwu8a | Can the violation of parental autonomy be justified in the 2013 circumstances? |
| cord-269402-xzgfwu8a | Considering the State Comptroller's disapproval of the low compliance rates in certain Israeli regions, could the Ministry of Health have legally considered more intrusive measures of imposing OPVs in accordance with the Ordinance? |
| cord-269402-xzgfwu8a | Do mandatory OPVs enforced by criminal sanctions violate the right to parental autonomy? |
| cord-269402-xzgfwu8a | Is a law which authorizes health officials to mandate OPVs in order to eradicate polio enacted for a proper purpose? |
| cord-269402-xzgfwu8a | Is a mandatory OPV enforced by criminal sanctions the least autonomy- infringing intervention? |
| cord-269402-xzgfwu8a | Should the UK introduce compulsory vaccination? |
| cord-269402-xzgfwu8a | Was it legally legitimate to impose OPVs in 2013 in accordance with the public health ordinance, 1940? |
| cord-269402-xzgfwu8a | What does social justice require for the public's health? |
| cord-269402-xzgfwu8a | When is an epidemic an epidemic? |
| cord-269402-xzgfwu8a | Would a mandatory OPV be an effective intervention and promote the eradication of polio? |
| cord-269402-xzgfwu8a | Would it be legally justified to impose vaccination in Israel? |
| cord-269402-xzgfwu8a | Would it be legally legitimate to impose OPVs in accordance with a new public health law? |
| cord-355689-mo4mvwch | Furthermore, most previous works[ 44][ 45][ 46][ 47][ 48][ 49][ 50][ 51][ 52] often assume that the vaccine has a perfect efficacy, which will endow the complete immunity for the inoculated individuals, but an interesting topic is on how the epidemic spreads when the vaccine is not fully effective for the disease( i.e., 100% efficacy)? |
| cord-355689-mo4mvwch | Hub nodes inhibit the outbreak of epidemic under voluntary vaccination Policy evaluation for the subsidy for influenza vaccination in elderly Does subsidy work? |
| cord-355689-mo4mvwch | The influence of social norms on the dynamics of vaccinating behavior for paediatric infectious diseases Risk assessment for infectious disease and its impact on voluntary vaccination behavior in social networks Can influenza epidemics be prevented by voluntary vaccination? |
| cord-309587-xc4jaw31 | Can rabies be eradicated? |
| cord-309587-xc4jaw31 | Emerging epidemic dog rabies in coastal South Africa: a molecular epidemiological analysis Re- evaluating the burden of rabies in Africa and Asia Overview of rabies in the Americas Current status of human rabies transmitted by dogs in Latin America Rabies on Flores Island, Indonesia: is eradication possible in the near future? |
| cord-309587-xc4jaw31 | World Health Organization( WHO/ Rab Dog rabies and its control Is it possible to vaccinate young canids against rabies and to protect them? |
| cord-279026-s3yx62u6 | Are there changes in the carrier through the incorporation of new foreign genes? |
| cord-279026-s3yx62u6 | Are there changes in the tissue tropism of the virus? |
| cord-279026-s3yx62u6 | First, is the effect consistent? |
| cord-279026-s3yx62u6 | Is there exchange of genetic information with other wild type or vaccine strains of the carrier? |
| cord-279026-s3yx62u6 | Is there reversion to virulence through the incorporation of complementation genes? |
| cord-279026-s3yx62u6 | Second, is the effect specific? |
| cord-279026-s3yx62u6 | Will the carrier spread unwanted genes such as antibiotic resistance into the environment? |
| cord-274052-rjud75iz | Are we vaccinating too much? |
| cord-274052-rjud75iz | Did I ask too much from the client? |
| cord-274052-rjud75iz | Did I choose the right place, time, situation, climate? |
| cord-274052-rjud75iz | Did I feel pressed for time? |
| cord-274052-rjud75iz | Did I ignore( or even induce) worries in the client? |
| cord-274052-rjud75iz | Did I practice active listening? |
| cord-274052-rjud75iz | Did I properly structure the interview( introduction, aim, course, conclusion)? |
| cord-274052-rjud75iz | Did I respect the listener's need for pauses? |
| cord-274052-rjud75iz | Did I show empathy? |
| cord-274052-rjud75iz | Did I stimulate the client to ask questions? |
| cord-274052-rjud75iz | Did I take in all messages? |
| cord-274052-rjud75iz | Did I use diversion strategies( stray, digress, evade, deviate, disparage, patronize, condescend)? |
| cord-274052-rjud75iz | Did I use killer phrases? |
| cord-274052-rjud75iz | Did I use the correct query technique? |
| cord-274052-rjud75iz | In veterinary medicine, overvaccination rather refers to vaccinating with excessive frequency, which has been controversial for more that a decade(''Are we vaccinating too much?'' |
| cord-274052-rjud75iz | The proposal is to assess the result of vaccination by asking the question: did the vaccinee's immune system recognise the antigen? |
| cord-274052-rjud75iz | Was my client's reality the same as mine? |
| cord-274052-rjud75iz | What do you suggest as an answer? |
| cord-274052-rjud75iz | When lecturing about pet vaccination and vaccine use in the last decade, I used to confront veterinary audiences with the following scenario:'A pediatrician client presents her cat to a vet and asks:''Doctor, why do I need to pay you a yearly visit for revaccination of my cat? |
| cord-274052-rjud75iz | Why an interview? |
| cord-274052-rjud75iz | Why has veterinary medicine adopted a practice that causes raised eyebrows in the biomedical environment, e.g. when talking to immunologists? |
| cord-274052-rjud75iz | Why yearly? |
| cord-343183-5jlnw6e0 | no Brasil? |
| cord-275033-y9z9l0ji | Definition of Policy What is Policy? |
| cord-275033-y9z9l0ji | Did Children Receive DTaP Vaccinations Earlier after Accelerated DTaP Immunization Recommendations by Local Public Health during 2003 Pertussis Outbreaks in Oregon?: |
| cord-275033-y9z9l0ji | States? |
| cord-275033-y9z9l0ji | The National Vaccine Advisory Committee The president's child immunization initiative-- a summary of the problem and the response Effectiveness of a practice- based intervention to increase vaccination rates and reduce missed opportunities? |
| cord-290133-4ou7ubb4 | Even if it can remain aerosolized and viable for a prolonged period of time, just how infectious is it by this route? |
| cord-290133-4ou7ubb4 | If it can be aerosolized, for how long does it remain viable, and how far can it be carried? |
| cord-290133-4ou7ubb4 | In vitro activity of potential anti- poxvirus agents Expression of mouse interleukin-4 by a recombinant ectromelia virus suppresses cytolytic lymphocyte responses and overcomes genetic resistance to mousepox Smallpox: anything to declare? |
| cord-290133-4ou7ubb4 | Is the N95 respirator appropriate for occupational protection against SARS? |
| cord-290133-4ou7ubb4 | The case for voluntary smallpox vaccination Smallpox and smallpox vaccination The 1972 smallpox outbreak in Khulna Municipality, Bangladesh Can postexposure vaccination against smallpox succeed? |
| cord-290133-4ou7ubb4 | The questions are these:( 1) Can smallpox virus be aerosolized? |
| cord-288933-q3b0r5ig | Assessor question: Where would you find information regarding the drug class, action and side effects of this drug? |
| cord-288933-q3b0r5ig | Case for pharmacist administered vaccinations in Australia Current research: Incorporating vaccine administration in pharmacy curriculum: Preparing students for emerging roles Australia's first pharmacist immunisation pilot- who did pharmacists inject? |
| cord-265472-b1s4stvz | 5 case reports Cutaneous polyarteritis nodosa in a child following hepatitis B vaccination Systemic polyarteritis nodosa following hepatitis B vaccination Kawasaki disease in an infant following immunisation with hepatitis B vaccine Yellow fever vaccination and Kawasaki disease Churg- strauss vasculitis with brain involvement following hepatitis B vaccination ANCA- associated vasculitis following influenza vaccination: causal association or mere coincidence? |
| cord-265472-b1s4stvz | : does it induce autoimmunity and cutaneous sclerosis? |
| cord-265472-b1s4stvz | A review on the association between inflammatory myopathies and vaccination Fibromyalgia and overlapping disorders: the unifying concept of central sensitivity syndromes Etiology of fibromyalgia: the possible role of infection and vaccination Infection and vaccination in chronic fatigue syndrome: myth or reality? |
| cord-265472-b1s4stvz | Bullous pemphigoid after herpes zoster vaccine administration: association or coincidence? |
| cord-265472-b1s4stvz | Can immunisation trigger rheumatoid arthritis? |
| cord-265472-b1s4stvz | Does influenza vaccination induce bullous pemphigoid? |
| cord-265472-b1s4stvz | The immunobiology of aluminium adjuvants: how do they really work? |
| cord-265472-b1s4stvz | The mosaic of autoimmunity Infections and autoimmunity- friends or foes? |
| cord-265472-b1s4stvz | The pro- oxidant activity of aluminum Regulatory role of zinc during aluminium- induced altered carbohydrate metabolism in rat brain Aluminum and Alzheimer's disease: after a century of controversy, is there a plausible link? |
| cord-265472-b1s4stvz | Vaccine safety datalink team Efficacy and duration of immunity after yellow fever vaccination: systematic review on the need for a booster every 10 years Risk of yellow fever vaccine- associated viscerotropic disease among the elderly: a systematic review Bacillus calmette- guérin immunotherapy for genitourinary cancer Arthritis after BCG vaccine in a healthy woman Dermatomyositis after B.C.G. vaccination Aetiopathogenesis of Takayas's arteritis and BCG vaccination: the missing link? |
| cord-265472-b1s4stvz | anti- TRIB2 autoantibody positive patient IgG causes hypothalamic orexin neuron loss and sleep attacks in mice Is narcolepsy a classical autoimmune disease? |
| cord-265472-b1s4stvz | autoimmunity, effector T cell activation due to infection, or T cell independent, major histocompatibility complex class II induced neuronal loss? |
| cord-265472-b1s4stvz | following human papillomavirus vaccination HBV vaccine and dermatomyositis: is there an association? |
| cord-265472-b1s4stvz | interferon alpha-2b confer additional benefit in the adjuvant treatment of high- risk melanoma? |
| cord-265472-b1s4stvz | vaccination- a case report Human papillomavirus( HPV) vaccine policy and evidence- based medicine: are they at odds? |
| cord-354818-yf5lvbs1 | Should professionals caring for children be vaccinated? |
| cord-299475-p6cc98xa | How can vaccination coverage be improved? |
| cord-299475-p6cc98xa | Triplereassortant swine influenza A( H1) in humans in the United States Impact of SARS on avian influenza preparedness in healthcare workers Impact of severe acute respiratory syndrome and the perceived avian influenza epidemic on the increased rate of influenza vaccination among nurses in Hong Kong Which determinants should be targeted to increase influenza vaccination uptake among health care workers in nursing homes? |
| cord-309268-sig0h723 | an inventory of strategies to reach target populations and optimise vaccination uptake seasonal influenza vaccination coverage rates in 10 countries in Africa Vaccination coverage rates in eleven European countries during two consecutive influenza seasons Influenza vaccination uptake and socioeconomic determinants in 11 European countries Patient's perceptions and information provided by the public health service are predictors for influenza vaccine uptake Factors influencing acceptance of influenza vaccination given in an ED Predictors of flu vaccination among urban Hispanic children and adults Influenza vaccination coverage against seasonal and pandemic influenza and their determinants in France: a cross- sectional survey Healthy young and middle age adults: what will it take to vaccinate them for influenza? |
| cord-343347-guciupc8 | Efficacy or effectiveness? |
| cord-343347-guciupc8 | In 2010, Weinberg and Szilagyl eloquently approached the issues of efficacy and effectiveness clarifying the road to correctly answer the relevant but complex question:"How well does the candidate vaccine prevent the disease for which it was developed? |
| cord-343347-guciupc8 | The aging innate immune system Reduction in acute gastroenteritis hospitalizations among us children after introduction of rotavirus vaccine: analysis of hospital discharge data from 18 US states Resolving the pneumococcal vaccine controversy: are there alternatives to randomized clinical trials? |
| cord-321993-uazc3lyg | After tortuous millennia of epidemic disease and hundreds of millions dead, who would argue that this was not a most wonderful gift given by humankind to itself? |
| cord-321993-uazc3lyg | How much of human life should be assigned to individuality, and how much to society?" |
| cord-321993-uazc3lyg | In On Liberty, in Chapter IV, John Stuart Mill asks,"What then is the rightful limit to the sovereignty of the individual over himself? |
| cord-321993-uazc3lyg | It can eliminate a disease from the world for all time, saving all future generations, but at what cost? |
| cord-321993-uazc3lyg | We human beings are remarkable in many ways, but why are we remarkable for playing host to so many infectious agents? |
| cord-321993-uazc3lyg | What does the world look like in the face of measles? |
| cord-321993-uazc3lyg | What is the safety of vaccination? |
| cord-321993-uazc3lyg | Where does the authority of society begin? |
| cord-321993-uazc3lyg | Why is it that we must maintain high levels of vaccine coverage to prevent infectious agents from sickening or even killing large swaths of the population? |
| cord-272512-gevrlcvy | Does this confirm trafficking of antigen- specific memory cells following exposure of the nasopharynx to transgenic alfalfa or does this suggest that vaccine antigen survived rumination and sensitized GALT by transport across the intestinal epithelium? |
| cord-272512-gevrlcvy | Is the edible format the future for veterinary vaccines in ruminanting animals? |
| cord-272512-gevrlcvy | Why vaccinate mucosally? |
| cord-300900-0wfsr4iw | A review of the key factors to improve adult immunization coverage rates: What can the clinician do? |
| cord-300900-0wfsr4iw | Analysis of three years of WHO/ UNICEF Joint Reporting Form data Trends in seasonal influenza vaccine coverage of target groups in France Trajectories of seasonal influenza vaccine uptake among French people with diabetes: a nationwide retrospective cohort study Comparison of dual influenza and pneumococcal polysaccharide vaccination with influenza vaccination alone for preventing pneumonia and reducing mortality amongthe elderly: A meta- analysis Cost- utility analysis of 10-and 13-valent pneumococcal conjugate vaccines: protection at what price in the Thai context? |
| cord-300900-0wfsr4iw | How close are countries of the WHO European Region to achieving the goal of vaccinating 75% of key risk groups against influenza? |
| cord-319226-yvgvyif0 | Toolkits A Psychological perspective on economic Biased assimilation and attitude polarization: The effects of prior theories on subsequently considered evidence Changes in suicide rates following media reports on celebrity suicide: A meta- analysis Mass killings in the United States from 2006 to 2013: Social contagion or random clusters? |
| cord-319226-yvgvyif0 | Who is responsible for the failure to vaccinate? |
| cord-319226-yvgvyif0 | Will it be mandatory? |
| cord-319226-yvgvyif0 | Will there be penalties for non- compliance? |
| cord-348218-wyy4rvqb | A framework for health professionals From social media to mainstream news: The information flow of the vaccine- autism controversy in the US, Canada, and the UK Vaccination communication strategies: What have we learned, and lost, in 200 years I approve this message: Effects of sponsorship, ad tone and reactance in 2008 presidential advertising National and DHB immunisation data Reinforcement or reactance? |
| cord-348218-wyy4rvqb | At the time of writing this article a billboard produced by the New Zealand anti- vaccination group Warnings About Vaccination Expectations( WAVES) was placed on Auckland's southern motorway posing the question''If you knew the ingredients in a vaccine would you RISK it?" |
| cord-348218-wyy4rvqb | Effects of equivalence framing on the perceived truth of political messages and the trustworthiness of politicians Helpful or harmful? |
| cord-348218-wyy4rvqb | The HPV vaccine and the media: How has the topic been covered and what are the effects on knowledge about the virus and cervical cancer? |
| cord-285760-y37ji92k | 9 strain of live attenuated mumps vaccine in comparison with the Jeryl Lynn strain Safety and characterization of the immune response engendered by two combined measles, mumps and rubella vaccines Horizontal transmission of the Leningrad-3 live attenuated mumps vaccine virus Mumps antibody levels among students before a mumps outbreak: in search of a correlate of immunity Primary vaccine failure after 1 dose of varicella vaccine in healthy children Outbreak of mumps in a vaccinated child population: a question of vaccine failure? |
| cord-285760-y37ji92k | : a ten year longitudinal cohort study of American children born in the 1990s Duration of humoral immunity to common viral and vaccine antigens Mumps outbreaks in vaccinated populations: are available mumps vaccines effective enough to prevent outbreaks? |
| cord-285760-y37ji92k | Available online at: https://vaccineschedule.ecdc.europa.eu/Scheduler/ByDisease? |
| cord-285760-y37ji92k | Correlates of lymphoproliferative responses to measles, mumps, and rubella( MMR) virus vaccines following MMR- II vaccination in healthy children Detection of mumps virus- specific memory B cells by transfer of peripheral blood mononuclear cells into immune- deficient mice Are cases of mumps in vaccinated patients attributable to mismatches in both vaccine T- cell and B- cell epitopes? |
| cord-285760-y37ji92k | Does the medical profession and the"pro- vaccine"message contribute to the public skepticism regarding immunization? |
| cord-285760-y37ji92k | How is a response to a vaccine determined? |
| cord-285760-y37ji92k | Is it time to shift the medical and public perception paradigm from"protection of infection following vaccination"to"protection from serious clinical mumps manifestation"? |
| cord-285760-y37ji92k | Molecular signatures of antibody responses derived from a systems biology study of five human vaccines Influenza immunization elicits antibodies specific for an egg- adapted vaccine strain Influenza vaccine failure: failure to protect or failure to understand? |
| cord-285760-y37ji92k | RT%2DPCR%20and% 20viral%20culture, aid%20in%20diagnosing%20mumps%20infection Diagnosis of acute mumps infection during an outbreak in a highly vaccinated population: mumps RNA or mumps IgM detection? |
| cord-285760-y37ji92k | The case numbers of more recent mumps outbreaks should always be assessed with this question in mind; are the number of mumps cases increasing, or/ and are we better at diagnosing an acute infection? |
| cord-285760-y37ji92k | The establishment of surrogates and correlates of protection: useful tools for the licensure of effective influenza vaccines? |
| cord-285760-y37ji92k | The role of systems biology approaches in determining molecular signatures for the development of more effective vaccines Adjuvants and alternative routes of administration towards the development of the ideal influenza vaccine Trained immunity- based vaccines: a new paradigm for the development of broad- spectrum anti- infectious formulations Could an unrelated live attenuated vaccine serve as a preventive measure to dampen septic inflammation associated with COVID-19 infection? |
| cord-285760-y37ji92k | Therefore, does"immunity"refer to sterile immunity or solely to protection from symptomatic infection? |
| cord-285760-y37ji92k | Therefore, if a correlate or surrogate correlate is unobtainable to define an individual's protection to mumps, should we re- consider and re- focus efforts on optimizing the vaccine using available historical clinical and trial data? |
| cord-285760-y37ji92k | What defines an effective vaccine, or what constitutes vaccine failure? |
| cord-285760-y37ji92k | Why Do We Consider Antibodies to Be the Best Measurement of Vaccine Efficacy? |
| cord-285760-y37ji92k | key: cord-285760-y37ji92k authors: Connell, Anna R.; Connell, Jeff; Leahy, T. Ronan; Hassan, Jaythoon title: Mumps Outbreaks in Vaccinated Populations — Is It Time to Re- assess the Clinical Efficacy of Vaccines? |
| cord-285760-y37ji92k | the nova scotia experience Mumps outbreak and laboratory diagnosis Antibody Fab- Fc properties outperform titer in predictive models of SIV vaccine- induced protection Increase in mumps in Ireland in late Assessment of mumps virus- specific antibodies by different serological assays: which test correlates best with mumps immunity? |
| cord-285760-y37ji92k | why and what to do? |